{"organizations": [], "uuid": "00a8ad16eb340465f787992a97947754ffe5174d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180503.html", "section_title": "Archive News &amp; Video for Thursday, 03 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/regeneron-pharms-results/regenerons-first-quarter-profit-soars-92-percent-idUSL3N1SA3QV", "country": "US", "domain_rank": 408, "title": "Regeneron's first quarter profit soars 92 percent", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-05-03T18:35:00.000+03:00", "replies_count": 0, "uuid": "00a8ad16eb340465f787992a97947754ffe5174d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/regeneron-pharms-results/regenerons-first-quarter-profit-soars-92-percent-idUSL3N1SA3QV", "ord_in_thread": 0, "title": "Regeneron's first quarter profit soars 92 percent", "locations": [], "entities": {"persons": [{"name": "tamara mathias", "sentiment": "none"}, {"name": "shailesh kuber", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "regeneron", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "regeneron pharmaceuticals inc", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 3 (Reuters) - Regeneron Pharmaceuticals Inc on Thursday posted a 92 percent rise in quarterly profit, as demand for its flagship eye treatment Eylea and eczema drug Dupixent increased.\nNet income rose to $478 million, or $4.16 per share, in the quarter ended March. 31, from $248.9 million, or $2.16 per share, a year ago.\nTotal revenue rose to $1.51 billion from $1.32 billion. (Reporting by Tamara Mathias in Bengaluru; Editing by Shailesh Kuber)\nOur ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-03T18:35:00.000+03:00", "crawled": "2018-05-04T17:04:28.006+03:00", "highlightTitle": ""}